Research
Featured research
Featured research topics
GLP-1
Oncology
Flu/RSV
Measles
Cardiovascular
Cyclosporiasis diagnoses reach historic levels in 2026 summer outbreak
Large language models to extract cancer staging data from clinical documentation at scale
GLP-1 medications associated with lower alcohol-related hospitalization risk
Peer-reviewed research found newer GLP-1 medications were associated with lower alcohol-related hospitalization risk among adults with alcohol use disorder.
GLP-1 RA prescription trends: January 2019 – June 2026
Early uptake of oral orforglipron (Foundayo pill) for obesity following FDA approval
Mortality risk may differ across antipsychotics used in Alzheimer’s disease
Measles outbreaks linked to increases in immunity testing among adults over 50
Truveta Research found measles titer testing among adults over 50 increased during the 2019 and 2025 outbreaks, with a sharp rise in Texas in 2025.
Emergency department visits related to e-bike and e-scooter injuries are rising rapidly among children and adolescents
Truveta Research finds e-bike and e-scooter injury ED visits rose 7.5-fold among children, with head and neck injuries most common.
Real-world study finds 1 in 7 patients returned to Humira after switching to an adalimumab biosimilar
A real-world study found 16% of patients switched back to Humira after starting an adalimumab biosimilar, highlighting transition challenges.
Understanding real-world patterns of increasing oral semaglutide dose for obesity
Shingrix vaccination is rising among newly eligible adults, but access gaps remain
Progesterone-containing hormone replacement therapy use is rising
Progesterone-containing hormone replacement therapy use is rising. Truveta Research found prescribing increased more than fourfold between 2018 and 2026.